Insider: Hansard Adam Chief Commercial Officer - Applied Therapeutics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 732,919 | 0 | 732,919 |
| Value | $828,198.47 | $0.00 | $828,198.47 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/14/2024 | DDS | 48,871 | Direct | COM | $5.39 | $263,414.69 | 732,919 |
| 11/30/2023 | DDS | 965 | Direct | COM | $1.97 | $1,901.05 | 381,790 |
| 09/27/2023 | DDS | 9,720 | Direct | COM | $2.70 | $26,244.00 | 382,755 |
| 01/11/2023 | DDS | 4,495 | Direct | COM | $0.91 | $4,090.45 | 92,475 |
| 05/26/2021 | DDS | 2,894 | Direct | COM | $18.35 | $53,104.90 | 33,570 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research